Search Orphan Drug Designations and Approvals
-
Generic Name: | (S)-1-((((1-Cyclohexylethyl)carbamoyl)oxy)methyl)-3-((2- nitrooxy)ethyl)carbamoyl)pyridin-1-ium iodide |
---|---|
Date Designated: | 02/29/2024 |
Orphan Designation: | Prevention of delayed graft function in patients undergoing solid organ transplantation. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Unicycive Therapeutics, Inc. 4300 El Camino Real, Suite 210 Los Altos, California 94022 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-